Led by Mark Davis, Ph.D., and Atul Butte, M.D., Ph.D., of Stanford University, Calif., the team of investigators received support from the National Institute of Allergy and Infectious Diseases (NIAID), as well as the National Heart, Lung, and Blood Institute and the National Cancer Institute, all part of the National Institutes of Health. Details about their work appear online at Nature Methods.
"Defining the status of the human immune system in health and disease is a major goal of human immunology research," says NIAID Director Anthony S. Fauci, M.D. "A method allowing clinicians to accurately and quickly characterize the many different immune cells in human blood would be a valuable research and diagnostic tool."
Over the past 15 years, the technology for gene expression microarrays, which allow investigators to identify and measure relative amounts of many different genes in parallel, has advanced tremendously. Today researchers can measure nearly every gene in the human genome using very small amounts of blood. However, blood contains numerous types of immune cells, such as lymphocytes, basophils and monocytes, and when microarray analysis is performed on this mixture, the interpretation of the results becomes problematic.
"Current methods that examine gene expression differences in mixtures of immune cells in blood do not take into account that, even among healthy individuals, there is a wide range of variation in the proportion of each cell type," says Dr. Davis. "This creates so-called noise that masks many differences in gene expression. Even when you do observe a difference, you do not know if this is due to a real difference or a reflection of the varying number of cell types in the mixture."
Until now, scientists had to separate out the cell types from a mixture prior to analysis to verify that actual changes in gene expression had occurred. But cell separation is time-consuming and costly, and requires large samples of blood, Dr. Davis adds.
To overcome such obstacles, the study team developed a computational approach called cell specific significance analysis of microarrays (csSAM).
"What csSAM does is marry the concepts of cell separation with the ease of analyzing large families of genes on a microarray," explains Dr. Butte. "Using a mathematical approach, we can virtually separate out the different cell types found in blood, determine the gene expression patterns of these cell types, and identify which changes in gene expression are due to actual disease and which are simply due to variations in the cell proportions."
Investigators first tested the csSAM approach using liver, brain and lung cells from rats. They began by analyzing the gene expression patterns in the three separate cell populations. Then they mixed the cells together in different known ratios and used the new mathematical approach to pick out the individual gene expression patterns of each cell subset in each mixture. Once they had confirmed that this analytical approach correctly identified the gene expression patterns of each individual cell subset in the mixtures, they tested csSAM on blood from kidney transplant patients who were either undergoing kidney rejection or who were stable.
Using a traditional approach to analyze the gene expression from blood, the investigators did not observe any differences between people undergoing transplant rejection and people with stable transplants. However, using the csSAM approach, they were able to pull out and measure from the mixture the gene expression patterns of five specific subsets of immune cells—monocytes, basophils, neutrophils, eosinophils, and lymphocytes, known as T and B cells. The researchers were able to identify more than 300 differences in monocyte gene expression between the two groups and more than 100 genes that were significantly increased. Because monocytes make up a smaller proportion of immune cells in the blood, compared to neutrophils or lymphocytes, the traditional analysis approach could not distinguish these differences in monocyte gene expression amongst all the other gene signals.
Methods that separate out specific cell populations from blood can lead to changes in expression of genes that are not due to disease but to the experimental manipulations. The csSAM approach circumvents these additional measures that may create even more noise in the samples.
Another advantage of the csSAM approach is that it could be applied to other high-throughput analyses of genes, proteins or other cellular products of any complex mixture of cells or tissues.
"In recent years, NIAID has placed increasing emphasis on supporting human immunology research, such as this study," says Daniel Rotrosen, M.D., of NIAID's Division of Allergy, Immunology, and Transplantation. "We are very encouraged that our investment has helped to develop this new analytical approach, which has the potential not only to define the parameters of the healthy human immune system, but also to help identify biomarkers of disease and develop more effective vaccines."
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.
Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at www.nhlbi.nih.gov.
NCI leads the National Cancer Program and the NIH effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI Web site at www.cancer.gov or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
Reference: S Shen-Orr et al. Extracting cell-type-specific gene expression differences from complex tissues. Nature Methods DOI: 10.1038/nmeth.1439 (2010).
Julie Wu | EurekAlert!
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy